Venmax Drugs and Pharmaceuticals Limited (BOM:531015)
India flag India · Delayed Price · Currency is INR
12.36
-2.66 (-17.71%)
At close: Nov 16, 2026

BOM:531015 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
132.5880.258.07---
Revenue Growth
333.17%894.04%----
Gross Profit
10.067.410.12-0.1--
Operating Income
3.731.40.05-1.12-1.94-1.36
Net Income
4.232.48-0.110.652.2618.46
Earnings Per Share
0.250.21-0.020.120.433.52
EPS Growth
-61.62%---72.09%-87.78%-

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
5.2862.3624.820.0300
Total Debt
-3.310.53.523.523.49
Net Cash (Debt)
5.2859.0624.33-3.5-3.52-3.49
Net Cash Growth
-79.02%142.75%----
Net Cash Per Share
0.325.104.64-0.67-0.67-0.67

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-116.86-109.96-22.90.02-0.0319.05
Capital Expenditures
-0.06-----
Free Cash Flow
-116.92-109.96-22.90.02-0.0319.05
Free Cash Flow Growth
-----621.97%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
7.59%9.23%1.52%---
Operating Margin
2.81%1.75%0.58%---
Pretax Margin
3.85%3.45%-1.75%---
Profit Margin
3.19%3.09%-1.30%---
FCF Margin
-88.19%-137.03%-283.69%---

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
48.49120.26----
PS Ratio
1.353.7218.51---